得克萨斯州休斯敦猴痘疫情的流行病学和控制措施

Abisola M. Oladimeji, Abayomi Joseph Afe, Louis Carillo, Courtney Hundley, Yufang Zhang, Stephen Long, Kirstin Short, Roger Sealy, Janeana White, David Persse
{"title":"得克萨斯州休斯敦猴痘疫情的流行病学和控制措施","authors":"Abisola M. Oladimeji,&nbsp;Abayomi Joseph Afe,&nbsp;Louis Carillo,&nbsp;Courtney Hundley,&nbsp;Yufang Zhang,&nbsp;Stephen Long,&nbsp;Kirstin Short,&nbsp;Roger Sealy,&nbsp;Janeana White,&nbsp;David Persse","doi":"10.1016/j.glohj.2024.08.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In the 2022–2023 global outbreak, the United States and state of Texas recorded a total of 31,277 and 3,085 confirmed monkeypox (Mpox) cases respectively as of November 2023. This study aims to investigate the demographic characteristics and risk factors of Mpox outbreak in Houston and document the epidemiologic control measures implemented with their outcomes.</div></div><div><h3>Methods</h3><div>Houston Health Department received reports of suspected Mpox cases via electronic case reports and laboratory reports from healthcare providers within Houston. These were then investigated and reclassified as either positive or negative using DNA polymerase chain reaction tests. All the reported cases received between May 2022 and January 2023 were included in this study using convenient sampling methods. Descriptive statistics using frequency distribution was used to analyze the sociodemographic, clinical features and travel history of the cases. A two-sided Chi-squared test was used to determine association between Mpox test results and risk factors with significant level set at <em>P</em> &lt; 0.05. Other infection control measures such as community engagement, health education, tracking and contact tracing, vaccination, referrals and laboratory sample logistics support were implemented by the health department.</div></div><div><h3>Results</h3><div>Out of the total of 1,625 suspected persons investigated for Mpox, 724 (44.6%) tested positive. Among the 724 confirmed cases, male was 700 (96.7%), females 20 (2.8%), transgender male 1 (0.1%), transgender female 3 (0.4%). Age groups 30–39 years constituted 43.6%, 18–29 years 27.4%, 40–49 years 18.2%, 50–59 years was 8%. Race distribution of positive cases was Whites 43.4%, African American 38.7%, Asian 1.4%. Risk factors with <em>P</em> &lt; 0.05 included male gender, age groups 30–39 years and 40–49 years, travel history to Mpox endemic areas, recent sexual contact with known or suspected Mpox cases, human immunodeficiency virus seropositivity. Identifying as gay and bisexual were also statistically significant risk factors for Mpox infection.</div></div><div><h3>Conclusion</h3><div>The timely implementation of primary and secondary prevention measures targeted at the most at-risk populations was very effective at curtailing the spread of Mpox infection within the city of Houston.</div></div>","PeriodicalId":73164,"journal":{"name":"Global health journal (Amsterdam, Netherlands)","volume":"8 3","pages":"Pages 133-139"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epidemiology and control of monkeypox outbreak in Houston, Texas\",\"authors\":\"Abisola M. Oladimeji,&nbsp;Abayomi Joseph Afe,&nbsp;Louis Carillo,&nbsp;Courtney Hundley,&nbsp;Yufang Zhang,&nbsp;Stephen Long,&nbsp;Kirstin Short,&nbsp;Roger Sealy,&nbsp;Janeana White,&nbsp;David Persse\",\"doi\":\"10.1016/j.glohj.2024.08.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>In the 2022–2023 global outbreak, the United States and state of Texas recorded a total of 31,277 and 3,085 confirmed monkeypox (Mpox) cases respectively as of November 2023. This study aims to investigate the demographic characteristics and risk factors of Mpox outbreak in Houston and document the epidemiologic control measures implemented with their outcomes.</div></div><div><h3>Methods</h3><div>Houston Health Department received reports of suspected Mpox cases via electronic case reports and laboratory reports from healthcare providers within Houston. These were then investigated and reclassified as either positive or negative using DNA polymerase chain reaction tests. All the reported cases received between May 2022 and January 2023 were included in this study using convenient sampling methods. Descriptive statistics using frequency distribution was used to analyze the sociodemographic, clinical features and travel history of the cases. A two-sided Chi-squared test was used to determine association between Mpox test results and risk factors with significant level set at <em>P</em> &lt; 0.05. Other infection control measures such as community engagement, health education, tracking and contact tracing, vaccination, referrals and laboratory sample logistics support were implemented by the health department.</div></div><div><h3>Results</h3><div>Out of the total of 1,625 suspected persons investigated for Mpox, 724 (44.6%) tested positive. Among the 724 confirmed cases, male was 700 (96.7%), females 20 (2.8%), transgender male 1 (0.1%), transgender female 3 (0.4%). Age groups 30–39 years constituted 43.6%, 18–29 years 27.4%, 40–49 years 18.2%, 50–59 years was 8%. Race distribution of positive cases was Whites 43.4%, African American 38.7%, Asian 1.4%. Risk factors with <em>P</em> &lt; 0.05 included male gender, age groups 30–39 years and 40–49 years, travel history to Mpox endemic areas, recent sexual contact with known or suspected Mpox cases, human immunodeficiency virus seropositivity. Identifying as gay and bisexual were also statistically significant risk factors for Mpox infection.</div></div><div><h3>Conclusion</h3><div>The timely implementation of primary and secondary prevention measures targeted at the most at-risk populations was very effective at curtailing the spread of Mpox infection within the city of Houston.</div></div>\",\"PeriodicalId\":73164,\"journal\":{\"name\":\"Global health journal (Amsterdam, Netherlands)\",\"volume\":\"8 3\",\"pages\":\"Pages 133-139\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global health journal (Amsterdam, Netherlands)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2414644724000460\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global health journal (Amsterdam, Netherlands)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2414644724000460","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景在2022-2023年全球猴痘疫情爆发期间,截至2023年11月,美国和德克萨斯州分别记录了31277例和3085例确诊猴痘病例。本研究旨在调查休斯顿猴痘疫情的人口特征和风险因素,并记录所实施的流行病学控制措施及其结果。方法休斯顿卫生局通过电子病例报告和实验室报告接收休斯顿医疗机构的猴痘疑似病例报告。然后,通过 DNA 聚合酶链反应测试对这些病例进行调查并重新分类为阳性或阴性。本研究采用方便的抽样方法,将 2022 年 5 月至 2023 年 1 月期间收到的所有报告病例纳入研究范围。研究采用频数分布描述性统计来分析病例的社会人口学、临床特征和旅行史。采用双侧卡方检验确定 Mpox 检测结果与风险因素之间的关联,显著性水平设定为 P < 0.05。卫生部门还采取了其他感染控制措施,如社区参与、健康教育、追踪和接触者追踪、疫苗接种、转诊和实验室样本物流支持等。在724例确诊病例中,男性700例(96.7%),女性20例(2.8%),变性男性1例(0.1%),变性女性3例(0.4%)。年龄组中,30-39 岁占 43.6%,18-29 岁占 27.4%,40-49 岁占 18.2%,50-59 岁占 8%。阳性病例的种族分布为白人 43.4%、非裔美国人 38.7%、亚裔 1.4%。P < 0.05 的风险因素包括男性、30-39 岁和 40-49 岁年龄组、曾到麻风腮流行区旅行、最近与已知或疑似麻风腮病例有性接触、人类免疫缺陷病毒血清阳性。结论针对高危人群及时实施一级和二级预防措施,能有效遏制麻风腮病毒在休斯顿市的传播。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Epidemiology and control of monkeypox outbreak in Houston, Texas

Background

In the 2022–2023 global outbreak, the United States and state of Texas recorded a total of 31,277 and 3,085 confirmed monkeypox (Mpox) cases respectively as of November 2023. This study aims to investigate the demographic characteristics and risk factors of Mpox outbreak in Houston and document the epidemiologic control measures implemented with their outcomes.

Methods

Houston Health Department received reports of suspected Mpox cases via electronic case reports and laboratory reports from healthcare providers within Houston. These were then investigated and reclassified as either positive or negative using DNA polymerase chain reaction tests. All the reported cases received between May 2022 and January 2023 were included in this study using convenient sampling methods. Descriptive statistics using frequency distribution was used to analyze the sociodemographic, clinical features and travel history of the cases. A two-sided Chi-squared test was used to determine association between Mpox test results and risk factors with significant level set at P < 0.05. Other infection control measures such as community engagement, health education, tracking and contact tracing, vaccination, referrals and laboratory sample logistics support were implemented by the health department.

Results

Out of the total of 1,625 suspected persons investigated for Mpox, 724 (44.6%) tested positive. Among the 724 confirmed cases, male was 700 (96.7%), females 20 (2.8%), transgender male 1 (0.1%), transgender female 3 (0.4%). Age groups 30–39 years constituted 43.6%, 18–29 years 27.4%, 40–49 years 18.2%, 50–59 years was 8%. Race distribution of positive cases was Whites 43.4%, African American 38.7%, Asian 1.4%. Risk factors with P < 0.05 included male gender, age groups 30–39 years and 40–49 years, travel history to Mpox endemic areas, recent sexual contact with known or suspected Mpox cases, human immunodeficiency virus seropositivity. Identifying as gay and bisexual were also statistically significant risk factors for Mpox infection.

Conclusion

The timely implementation of primary and secondary prevention measures targeted at the most at-risk populations was very effective at curtailing the spread of Mpox infection within the city of Houston.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Global health journal (Amsterdam, Netherlands)
Global health journal (Amsterdam, Netherlands) Public Health and Health Policy
CiteScore
5.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信